Tag: DAPT
HEAL coating holds potential to “alleviate some of the biggest concerns”...
This advertorial is sponsored by Acandis.
While intracranial stents are among the devices most commonly used by neurointerventionists, one challenge that hampers their utilisation in...
DAPT at discharge reduces stroke and mortality risk versus other drug...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT),...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Dual antiplatelet therapy comparable to thrombolysis in minor, non-disabling ischaemic stroke
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to...
Systematic review deems coated stents plus SAPT feasible in ruptured aneurysms
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to...
Similar complication rates observed following DAPT discontinuation within and past 90...
The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...
